x
ServiziMenu principaleHome
You are here: Home > Events > Past events > 2016 > 5th ESO Arab Countries Masterclass in Clinical Oncology
Print

5th ESO Arab Countries Masterclass in Clinical Oncology

30 ESCO credits

28.10.2016  -  30.10.2016

Cairo, Egypt

MASTERCLASS

Medical / clinical oncology

Description

Chairs: M.S. Aapro, CH - N. Pavlidis, GR - S. Khatib, JO
Host country chairs: H. Khaled, EG - M. Lotayef, EG


This is a 3-days clinically oriented educational programme dedicated to medical, clinical and radiation oncologists, who wish to improve their skills in oncology or those who are preparing for the national board exam. The programme focuses on breast, gynaecological, prostate, colorectal, lung cancers and on lymphomas and its covered by an international faculty of top experts.

The Masterclass offers:

• plenary lectures regarding state-of-the art clinical evaluation and treatments with reference to clinical guidelines concluding in takehome messages,
• clinical case presentations will be delivered by the participants in tumor board discussions as well as in divided small groups with the presence of the chairs and the faculty,
• a self-assessment test based on multiple choice questionnaire, will be provided to participants on the last day of the Masterclass

All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission


LEARNING OBJECTIVES
• Improve medical oncologists’ skills
• Practicing case discussion
• Deep focus on breast, gynaecological, prostate, lung and colorectal cancer, lymphomas


MAIN TOPICS
• Breast cancer
• Gynaecological cancer
• Prostate cancer
• Colorectal cancer
• Lung cancer
• Lymphomas



Held under the auspices of:  
   
 AMAAC  



General information

ORGANISING SECRETARIAT
Daniela Mengato
European School of Oncology (ESO)
Via Turati 29 - 20121 Milan, Italy
Tel:
Fax: +39 02 85464545
Email: dmengato@eso.net
+39 02 85464532


APPLICATIONS

Elena Fiore
Ph: +39 02 85464529
Email: efiore@eso.net

Faculty list


FACULTY

M.S. Aapro, Clinique de Genolier, Geneve, CH
N. Allahloubi, National Cancer Institute, Cairo University, EG
S. Al-Sukhun, Consultant in Medical Oncology and Hematology, Amman, JO
H.A. Azim Jr., Innate Pharma, Marseille, FR
M. El Naggar,
National Cancer Institute, Cairo University, EG

R. Gaafar, National Cancer Institute, Cairo University, EG
F. Geara, American University of Beirut Medical Center, LB
J. Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, FR
J. Khader, King Hussein Cancer Centre, Amman, JO
H. Khaled, National Cancer Institute, Cairo University, EG
S. Khatib, Arab Medical Association Against Cancer (AMAAC), Amman, JO
M. Lotayef, National Cancer Institute, Cairo University, EG
O. Mansour
, National Cancer Institute, Cairo University, EG
N. Mottet,
University Hospital, Saint Etienne, FR

O. Pagani, Oncology Institute of Southern Switzerland, Bellinzona, CH
N. Pavlidis, University of Ioannina, School of Medicine, Ioannina, GR
A. Shamseddine, American University of Beirut Medical Center, LB
J. Souglakos, University Hospital of Heraklion, GR
A. Stathis
, Oncology Institute of Southern Switzerland, Bellinzona, CH
J. B. Vermorken,
University Hospital of Antwerp, Edegem, BE

O. Z. Youssef, National Cancer Institute, Cairo University, EG



Programme

28 OCTOBER

     
 8:00   Welcome address
ESO - AMAAC - HOST CHAIRMAN  
 8:15   The concept of ESO Masterclasses
N. Pavlidis, GR
LUNG CANCER
Chairs: R. Gaafar, EG - J. Khader, JO

8:30


  Neoadjuvant and adjuvant chemotherapy in NSCLC               
R. Gaafar, EG
9:00
  Radiation treatment of lung cancer: an update
J. Khader, JO
 9:30   Targeted therapy and immunotherapy in advanced NSCLC
R. Gaafar, EG

10:00

 

Tumour board
Chairs: R. Gaafar, EG - J. Khader, JO

11:00

  Prayer and lunch break

COLORECTAL CANCER
Chairs: J. Souglakos, GR - F. Geara, LB

14:00

 

The role of radiotherapy in the management of rectal and anal cancer
F. Geara, LB

14:30

  Adjuvant and neoadjuvant therapy of colorectal cancer
J. Souglakos, GR

 15:00   Systemic treatment of colorectal cancer in metastatic disease
including immunotherapy

J. Souglakos, GR

 15:30   How do you manage colorectal cancer in the elderly?
M.S. Aapro, CH
 16:00   Coffee break
 16:30-
18:00
  Tumour board
Chairs: F. Geara, LB - J. Souglakos, GR
     

 

29 OCTOBER

 
BREAST CANCER
Chairs: O. Pagani, CH - N. Allahloubi, EG
8:30
  The role of surgery in breast cancer
O.Z. Youssef, EG

9:00


 

Indications of radiation therapy in early breast cancer
F. Geara, LB

9:30
 

Neoadjuvant and adjuvant chemotherapy and targeted treatments
J. Gligorov, FR

10:00

  Neoadjuvant and adjuvant hormonal therapy treatment
N. Allahloubi, EG

10:30

  Coffee break

11:00

  Systemic treatment of advanced disease in ER positive patients
O. Pagani, CH

 11:30

 

Systemic treatment of advanced disease in Her-2 positive patients
O. Pagani, CH

12:00

  Systemic treatment of advanced disease in "triple-negative"
S. Al-Sukhun, JO
12:30   Breast cancer in young women: impact of pregnancy on biology and
outcome

H. Azim jr, FR

13:00

  Lunch break

14:00   Tumour board
Chairs: F. Geara, LB - O. Pagani, CH - O.Z. Youssef, EG

16:00

 

Coffee break

16:30-
19:15

  Tumour board
Chairs: N. Allahloubi, EG - S. Al-Sukhun, JO - H. Azim, FR
     

 

30 OCTOBER

 

LYMPHOMA
Chairs: A. Stathis, CH - H. Khaled, EG  

8:30   

  What the clinical oncologist needs from the pathologist?
A. Stathis, CH

 9:00

 

Management of low grade lymphoma
H. Khaled, EG

 9:30   Management of high grade lymphoma
A. Stathis, CH

 10:00

 

Tumour board
Chairs:
A. Stathis, CH - H. Khaled, EG

11:00

 

Coffee break

GYNAECOLOGICAL CANCERS
Chairs: J.B. Vermorken, BE - M. El Naggar, EG
 11:30   Systemic management of epithelial ovarian cancer: where do we stand today?
J.B. Vermorken, BE
 12:00   Systemic therapy of cervical and endometrial carcinomas: any progress?
J.B. Vermorken, BE
 12:30   Tumour board
Chairs: J.B. Vermorken, BE - M. El Naggar, EG
 13:30   Lunch break

PROSTATE CANCER
Chairs: A. Shamseddine, LB - N. Mottet, FR

 14:30

  When not to treat in prostate cancer
N. Mottet, FR
 15:00   Advances in radiotherapy in early prostate cancer
M. Lotayef, EG

 15:30

 

Systemic treatment in castration-resistant prostate cancer
A. Shamseddine, LB

 16:00

  Tumour board
Chairs: M. Lotayef, EG - N. Mottet, FR - A. Shamseddine, LB
 17:00-
18:00
  Participants’ self-assessment test